| ID_events | cancer | TypeID | ImmuneCell | P | R | CorrelationPlot |
| ENSG00000260528.3,FAM157C | BLCA | EAG | T_cells_gamma_delta | 6.4182e-07 | 0.4233 |  |
| chr16:90168413-90170708:+ | BRCA | EER | Dendritic_cells_resting | 1.5463e-02 | -0.1524 |  |
| ENSG00000260528.3,FAM157C | BRCA | EAG | Dendritic_cells_resting | 1.6883e-02 | -0.1464 |  |
| ENSG00000260528.3,FAM157C | COAD | EAG | Dendritic_cells_activated | 2.5320e-02 | 0.3625 |  |
| chr16:90168413-90170708:+ | ESCA | EER | T_cells_follicular_helper | 1.6834e-02 | -0.2047 |  |
| ENSG00000260528.3,FAM157C | ESCA | EAG | T_cells_follicular_helper | 1.8871e-02 | -0.2011 |  |
| chr16:90168413-90170708:+ | HNSC | EER | B_cells_memory | 7.2852e-06 | 0.4421 |  |
| ENSG00000260528.3,FAM157C | HNSC | EAG | B_cells_memory | 9.7663e-06 | 0.4323 |  |
| chr16:90168413-90170708:+ | KIRC | EER | B_cells_naive | 2.8308e-02 | 0.3762 |  |
| ENSG00000260528.3,FAM157C | KIRC | EAG | B_cells_naive | 3.0779e-02 | 0.3710 |  |
| ENSG00000260528.3,FAM157C | KIRP | EAG | T_cells_follicular_helper | 1.8354e-03 | 0.4566 |  |
| chr16:90168413-90170708:+ | LAML | EER | T_cells_gamma_delta | 3.4806e-04 | 0.3811 |  |
| ENSG00000260528.3,FAM157C | LAML | EAG | T_cells_gamma_delta | 4.8404e-04 | 0.3704 |  |
| chr16:90168413-90170708:+ | LIHC | EER | Macrophages_M0 | 1.9235e-02 | -0.2680 |  |
| ENSG00000260528.3,FAM157C | LIHC | EAG | Macrophages_M0 | 2.4146e-02 | -0.2489 |  |
| chr16:90168413-90170708:+ | LUAD | EER | T_cells_CD8 | 3.6560e-04 | 0.2672 |  |
| ENSG00000260528.3,FAM157C | LUAD | EAG | T_cells_CD8 | 1.7004e-03 | 0.2336 |  |
| ENSG00000260528.3,FAM157C | LUSC | EAG | Neutrophils | 3.0776e-02 | -0.1437 |  |
| chr16:90168413-90170708:+ | OV | EER | B_cells_memory | 8.0661e-03 | 0.2514 |  |
| ENSG00000260528.3,FAM157C | OV | EAG | B_cells_memory | 1.4516e-02 | 0.2325 |  |
| ENSG00000260528.3,FAM157C | PAAD | EAG | Mast_cells_resting | 8.4370e-03 | 0.3550 |  |
| ENSG00000260528.3,FAM157C | PCPG | EAG | Neutrophils | 7.9471e-05 | 0.6025 |  |
| chr16:90168413-90170708:+ | PRAD | EER | Dendritic_cells_activated | 4.2371e-02 | 0.1905 |  |
| ENSG00000260528.3,FAM157C | PRAD | EAG | Dendritic_cells_activated | 2.6310e-02 | 0.2045 |  |
| ENSG00000260528.3,FAM157C | SARC | EAG | NK_cells_activated | 1.9778e-03 | 0.4691 |  |
| ENSG00000260528.3,FAM157C | SKCM | EAG | Dendritic_cells_resting | 4.6309e-02 | 0.2050 |  |
| chr16:90168413-90170708:+ | STAD | EER | T_cells_follicular_helper | 2.9923e-02 | 0.1528 |  |
| chr16:90168413-90170708:+ | TGCT | EER | Monocytes | 4.4503e-02 | 0.2078 |  |
| ENSG00000260528.3,FAM157C | THCA | EAG | Monocytes | 3.8267e-02 | 0.1760 |  |
| chr16:90168413-90170708:+ | UCEC | EER | Dendritic_cells_activated | 8.9286e-03 | 0.3294 |  |
| ENSG00000260528.3,FAM157C | UCEC | EAG | Dendritic_cells_activated | 6.5941e-03 | 0.3389 |  |
| ID_events | cancer | HallmarkType | Type | P | R | CorrelationPlot |
| ENSG00000260528.3,FAM157C | BLCA | GSVA_HALLMARK_TGF_BETA_SIGNALING | EAG | 2.0292e-02 | -0.2050 |  |
| ENSG00000260528.3,FAM157C | BRCA | GSVA_HALLMARK_INFLAMMATORY_RESPONSE | EAG | 4.8133e-02 | -0.1213 |  |
| ENSG00000260528.3,FAM157C | COAD | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EAG | 7.1450e-04 | 0.5250 |  |
| ENSG00000260528.3,FAM157C | ESCA | GSVA_HALLMARK_TGF_BETA_SIGNALING | EAG | 5.0872e-03 | 0.2389 |  |
| chr16:90168413-90170708:+ | ESCA | GSVA_HALLMARK_TGF_BETA_SIGNALING | EER | 4.9951e-03 | 0.2394 |  |
| ENSG00000260528.3,FAM157C | GBM | GSVA_HALLMARK_NOTCH_SIGNALING | EAG | 1.4895e-02 | 0.3824 |  |
| chr16:90168413-90170708:+ | GBM | GSVA_HALLMARK_DNA_REPAIR | EER | 2.4113e-02 | 0.3702 |  |
| chr16:90168413-90170708:+ | HNSC | GSVA_HALLMARK_FATTY_ACID_METABOLISM | EER | 4.9517e-02 | -0.2021 |  |
| chr16:90168413-90170708:+ | KIRC | GSVA_HALLMARK_APICAL_SURFACE | EER | 3.5590e-02 | 0.3617 |  |
| ENSG00000260528.3,FAM157C | KIRC | GSVA_HALLMARK_APICAL_SURFACE | EAG | 2.4350e-02 | 0.3855 |  |
| ENSG00000260528.3,FAM157C | KIRP | GSVA_HALLMARK_IL6_JAK_STAT3_SIGNALING | EAG | 1.2926e-02 | 0.3719 |  |
| ENSG00000260528.3,FAM157C | LAML | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EAG | 1.4144e-05 | -0.4519 |  |
| chr16:90168413-90170708:+ | LAML | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EER | 1.9868e-04 | -0.3952 |  |
| ENSG00000260528.3,FAM157C | LGG | GSVA_HALLMARK_HYPOXIA | EAG | 6.1489e-03 | -0.2313 |  |
| ENSG00000260528.3,FAM157C | LIHC | GSVA_HALLMARK_HEME_METABOLISM | EAG | 5.8845e-03 | 0.3017 |  |
| chr16:90168413-90170708:+ | LIHC | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EER | 8.8169e-03 | 0.2985 |  |
| ENSG00000260528.3,FAM157C | LUSC | GSVA_HALLMARK_PEROXISOME | EAG | 4.5082e-02 | 0.1334 |  |
| chr16:90168413-90170708:+ | LUSC | GSVA_HALLMARK_PEROXISOME | EER | 2.5940e-02 | 0.1498 |  |
| ENSG00000260528.3,FAM157C | OV | GSVA_HALLMARK_MYC_TARGETS_V1 | EAG | 1.3667e-03 | 0.3016 |  |
| chr16:90168413-90170708:+ | OV | GSVA_HALLMARK_MYC_TARGETS_V1 | EER | 6.9882e-04 | 0.3184 |  |
| chr16:90168413-90170708:+ | PRAD | GSVA_HALLMARK_ANGIOGENESIS | EER | 1.6062e-02 | 0.2251 |  |
| ENSG00000260528.3,FAM157C | PRAD | GSVA_HALLMARK_ANGIOGENESIS | EAG | 2.5747e-02 | 0.2053 |  |
| ENSG00000260528.3,FAM157C | SARC | GSVA_HALLMARK_APICAL_JUNCTION | EAG | 5.1973e-03 | 0.4284 |  |
| chr16:90168413-90170708:+ | STAD | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EER | 2.4702e-02 | 0.1580 |  |
| ENSG00000260528.3,FAM157C | STAD | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EAG | 2.8356e-02 | 0.1535 |  |
| ENSG00000260528.3,FAM157C | TGCT | GSVA_HALLMARK_APICAL_SURFACE | EAG | 2.8193e-02 | 0.2252 |  |
| chr16:90168413-90170708:+ | THCA | GSVA_HALLMARK_GLYCOLYSIS | EER | 1.3556e-02 | 0.2128 |  |
| ID_events | cancer | Drug | Type | P | R | CorrelationPlot |
| ENSG00000260528.3,FAM157C | BLCA | AICAR | EAG | 1.9384e-03 | 0.2715 |  |
| chr16:90168413-90170708:+ | BLCA | AZD6482 | EER | 4.7776e-03 | 0.2528 |  |
| chr16:90168413-90170708:+ | BRCA | FTI.277 | EER | 6.5007e-03 | -0.1710 |  |
| ENSG00000260528.3,FAM157C | BRCA | FTI.277 | EAG | 2.0208e-03 | -0.1885 |  |
| chr16:90168413-90170708:+ | CESC | Bosutinib | EER | 1.2812e-02 | 0.2212 |  |
| ENSG00000260528.3,FAM157C | CESC | Bosutinib | EAG | 7.2172e-03 | 0.2373 |  |
| ENSG00000260528.3,FAM157C | COAD | CGP.60474 | EAG | 2.5458e-02 | 0.3622 |  |
| chr16:90168413-90170708:+ | ESCA | JNK.9L | EER | 3.3687e-03 | 0.2497 |  |
| ENSG00000260528.3,FAM157C | ESCA | JNK.9L | EAG | 3.4373e-03 | 0.2492 |  |
| ENSG00000260528.3,FAM157C | GBM | GDC0941 | EAG | 4.2694e-02 | 0.3221 |  |
| chr16:90168413-90170708:+ | KIRC | AZD6244 | EER | 1.2592e-02 | 0.4234 |  |
| ENSG00000260528.3,FAM157C | KIRC | AZD6244 | EAG | 1.6261e-02 | 0.4092 |  |
| ENSG00000260528.3,FAM157C | KIRP | CGP.082996 | EAG | 4.0595e-03 | -0.4247 |  |
| ENSG00000260528.3,FAM157C | LAML | Gefitinib | EAG | 3.4450e-03 | -0.3138 |  |
| chr16:90168413-90170708:+ | LAML | Gefitinib | EER | 5.7893e-03 | -0.2987 |  |
| ENSG00000260528.3,FAM157C | LGG | Etoposide | EAG | 7.6917e-03 | -0.2252 |  |
| chr16:90168413-90170708:+ | LIHC | AICAR | EER | 2.2283e-02 | -0.2619 |  |
| chr16:90168413-90170708:+ | LUAD | KIN001.135 | EER | 3.8386e-02 | 0.1571 |  |
| ENSG00000260528.3,FAM157C | LUAD | CGP.60474 | EAG | 4.7522e-02 | 0.1488 |  |
| ENSG00000260528.3,FAM157C | LUSC | Bortezomib | EAG | 8.6251e-03 | -0.1743 |  |
| chr16:90168413-90170708:+ | LUSC | Bortezomib | EER | 3.5469e-03 | -0.1954 |  |
| ENSG00000260528.3,FAM157C | OV | CCT007093 | EAG | 2.0710e-04 | 0.3467 |  |
| chr16:90168413-90170708:+ | OV | CCT007093 | EER | 4.8964e-05 | 0.3771 |  |
| ENSG00000260528.3,FAM157C | PAAD | AICAR | EAG | 5.9420e-03 | -0.3697 |  |
| ENSG00000260528.3,FAM157C | PCPG | BIRB.0796 | EAG | 4.1568e-02 | -0.3367 |  |
| chr16:90168413-90170708:+ | PRAD | AMG.706 | EER | 2.1317e-03 | -0.2848 |  |
| ENSG00000260528.3,FAM157C | PRAD | Metformin | EAG | 5.1572e-03 | 0.2559 |  |
| ENSG00000260528.3,FAM157C | SARC | BMS.754807 | EAG | 4.3846e-03 | -0.4359 |  |
| ENSG00000260528.3,FAM157C | SKCM | BI.D1870 | EAG | 1.6028e-02 | 0.2465 |  |
| chr16:90168413-90170708:+ | SKCM | Cisplatin | EER | 7.8920e-03 | -0.2799 |  |
| chr16:90168413-90170708:+ | STAD | AZ628 | EER | 2.8081e-04 | -0.2530 |  |
| ENSG00000260528.3,FAM157C | STAD | AZ628 | EAG | 2.6932e-04 | -0.2525 |  |
| chr16:90168413-90170708:+ | TGCT | Elesclomol | EER | 3.1841e-02 | 0.2216 |  |
| chr16:90168413-90170708:+ | THCA | AG.014699 | EER | 2.8939e-02 | 0.1888 |  |
| ENSG00000260528.3,FAM157C | THYM | JNK.Inhibitor.VIII | EAG | 3.1899e-02 | 0.3634 |  |